October 2016

New Indications

Gadovist 1.0 (gadobutrol) is now also indicated in adults and children including full-term newborns for: contrast enhancement in whole body MRI including head and neck region, thoracic space, breast, abdomen (pancreas, liver and spleen), pelvis (prostate, bladder and uterus), retroperitoneal space (kidney), extremities and musculoskeletal system; and contrast enhancement in cardiac MRI including assessment of rest and pharmacological stress perfusion and delayed enhancement.

Xiaflex (collagenase clostridium histolyticum) is now also indicated for: the treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629